Postoperative hepatitis - Biotech, Pharma and Life Science Channel

07:51 EDT 19th September 2014 | BioPortfolio

PubMed Articles [3891 Associated PubMed Articles listed on BioPortfolio]

Simeprevir (Olysio) for chronic hepatitis c.

Hepatobiliary/Pancreas Pathology: SC11-1 LIVER PATHOLOGY ALGORITHMS FOR THE NON-SPECIALIST: DIFFUSE LIVER PATHOLOGY.

Pathological lesions occur in the liver in primary hepatic disorders and in extrahepatic/ systemic diseases with hepatic involvement. Diseases may have acute or chronic manifestations. Comorbidities m...

Cytopathology: SS06-1 A WELL-DIFFERENTIATED HEPATOCELLULAR NODULAR LESION IN THE LIVER OF A WOMAN.

The differential diagnoses of fine needle aspiration (FNA) biopsy of a well-differentiated hepatocellular nodule (WDHN) in a woman with hepatitis B cirrhosis are discussed. Radiological diagnosis was ...

Introduction on postoperative nutritional support in neonatal cardiac surgery.

Malnutritionis common innewborn patients after cardiac surgery, because of the low metabolic reserves, increased energy expenditure caused by the injury, and reduced or delayed nutritional support the...

Strategies in the Prevention of the Formation of Postoperative Adhesions in Digestive Surgery: A Systematic Review of the Literature.

Postoperative intra-abdominal adhesions after GI surgery constitute a major burden for health care provision globally, causing chronic abdominal symptoms and necessitating repeated surgical interventi...

Editorial: can we afford the new direct-acting anti-virals for treatment of genotype 1 hepatitis C? Authors' reply.

Prevention of Postoperative Nausea and Vomiting: A Thought on Ondansetron.

Noninvasive scoring algorithm to identify significant liver fibrosis among treatment-naive chronic hepatitis C patients.

Staging for liver fibrosis is recommended in the management of hepatitis C as an argument for treatment priority. Our aim was to construct a noninvasive algorithm to predict the significant liver fibr...

Hepatobiliary/Pancreas Pathology: SY11-3 PANCREATIC DUCTAL ADENOCARCINOMA: NEOADJUVANT THERAPIES AND PATHOLOGY.

Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal human malignancies with less than 5% five-year survival rate. Despite significant improvements in medical and surgical oncology and po...

Hepatobiliary/Pancreas Pathology: SY11-2 LIVER FLUKE AND CHOLANGIOCARCINOMA IN THAILAND.

In northeastern Thailand, prevalent risks for cholangiocarcinoma (CC) include infestation with liver fluke O. viverrini (OV), infection with HBV and HCV, and consumption of nitrosamine-rich foods. The...

News Articles [1425 Associated News Articles listed on BioPortfolio]

Two young Egyptian scientists at TUM win ISS project

Two researchers at Technische Universit-t M-nchen have won the 'International Space Station Research Competition' with their project 'Egypt Against Hepatitis C Virus.' As their prize, the scientists w...

MedMira Inc. (MIR) - Product Pipeline Analysis, 2014 Update

Recently added to the BioPortfolio report store, MedMira Inc. (MIR) - Product Pipeline Analysis, 2014 Update is a new report from GlobalData published on 2014-08-31. This 42-page report is available ...

Australia Sees Record Highs in Syphilis Cases and Hepatitis Deaths

(Science) – Public health experts in Australia are sounding alarms over a record number of new cases of syphilis and a dramatic rise in viral hepatitis deaths. Experts trace the spike in syphili...

Hepatitis B and C in pregnancy: a review and recommendations for care

Gilead Sciences: The Recent Dip In Share Price Creates A Buying Opportunity

By Balanced Investing:Gilead Sciences Inc. (NASDAQ:GILD) is one of the best performers in the biotech industry. Gilead's shares have risen by an astonishing 72% in the past year and 49% year-to-date, ...

What Makes Mylan Attractive

By Kanak Kanti De:Generic drugs maker Mylan Inc. (NASDAQ:MYL) has a robust portfolio of generic and branded drugs. In fact, Mylan is among the largest generics companies in the world. Not surprisingly...

UK NICE consults on draft guidance for hepatitis C drug Olysio

In draft guidance published today UK drugs watchdog the National Institute for Health and Care Excellence (NICE) has recommended US health care giant Johnson & Johnson subsidiary Janssen’s Olysio (s...

Biostar Pharmaceuticals, Inc. Files a PRC Patent Application for Oleanolic Acid Injection, its New Drug Product for Hepatitis B and Liver Cancer

XIANYANG, China, Sept. 18, 2014 /PRNewswire/ -- Biostar Pharmaceuticals, Inc. (NASDAQ: BSPM) ("Biostar" or the "Company"), a PRC-based manufacturer and marketer of pharmaceutical and health suppl...

Spring Bank Pharmaceuticals Announces NIH Collaboration for Testing of SB 9200 Against Multiple Viral Pathogens

MILFORD, Mass., Sept. 18, 2014 /PRNewswire/ -- Spring Bank Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of RNA viruses, today ...

Report reveals dangerous gap in understanding of hepatitis C transmission

A wide-ranging report by UNSW's Centre for Social Research in Health shows hepatitis C knowledge in young people and gay men is dangerously low.

Events [0 Results]

None

Companies [26 Associated Companies listed on BioPortfolio]

Advanced Biological Laboratories

Advanced Biological Laboratories (ABL), S.A., is a Medical Data Technology company founded in 2000 as a spin-off from CRP-Santé Luxembourg. ABL took control of TherapyEdge, Inc...

Ichor Medical Systems, Inc.

Ichor Medical Systems’ TriGrid™ Delivery System (TriGrid) is the first integrated and fully automated device for electroporation-mediated DNA administration in humans. I...

Transgene SA

Transgene (NYSE-Euronext: TNG), a member of the Institut Mérieux Group, is a biopharmaceutical company. It creates, develops and manufactures targeted immunotherapeutics for th...

AbbVie

AbbVie (NYSE:ABBV) is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott. AbbVie combines the focus and passion of a leading-edge biotech with the exp...

Okairos

Okairos is a clinical-stage biopharmaceutical company, developing genetic vaccines for major infectious diseases - including malaria, hepatitis C, influenza, respiratory syncytial...

Profectus BioSciences, Inc.

Profectus BioSciences, Inc. is a technology based vaccine company devoted to the treatment and prevention of chronic viral diseases with a goal of reducing morbidity and mo...

Viropro

Viropro Inc. (“Viropro”) operates through Viropro International Inc., a Canadian company with its Head Office in Montreal. Viropro International Inc. is specialized in the technology transfer, fo...

Enanta Pharmaceuticals, Inc.

Enanta Phatmaceuticals ARE A RESEARCH AND DEVELOPMENT-FOCUSED BIOTECHNOLOGY COMPANY that uses its robust chemistry-driven approach and drug discovery capabilities to create small molecule drugs in t...

Emergent BioSolutions

Emergent BioSolutions Inc. is a biopharmaceutical company dedicated to one simple mission—to protect life. We develop, manufacture and commercialize immunobiotics, consisting of vaccines and therape...

Cardax Pharmaceuticals

Cardax is a development stage life sciences company that devotes substantially all of its efforts to developing nutraceutical and pharmaceutical products that provide the anti-inf...

Clinical Trials [1798 Associated Clinical Trials listed on BioPortfolio]

An Efficacy and Safety Study of Simeprevir and Sofosbuvir With and Without Ribavirin in Participants With Recurrent Genotype 1 Hepatitis C Post-Orthotopic Liver Transplant

The purpose of this study is to evaluate sustained virologic response 12 weeks after the end of treatment (SVR12) following 12 weeks of simeprevir plus sofosbuvir with and without ribaviri...

Nitazoxanide Plus Ribavirin and Peginterferon for Therapy of Treatment Naive HCV Genotype 1 and HIV Coinfected Subjects

Infection with hepatitis C virus (HCV) can cause liver scarring, or cirrhosis, and this usually occurs more rapidly among people infected with both HCV and human immunodeficiency virus (HI...

Safety, Pharmacokinetics, and Pharmacodynamics of MK-8408 in Participants With Hepatitis C Infection (MK-8408-003)

This is a 3-part study of MK-8408 for participants with hepatitis C infection. Successive participants will be enrolled as dose levels are evaluated to find the maximum safe and well tole...

Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed-Dose Combination and Sofosbuvir + Ribavirin for Subjects With Chronic Hepatitis C Virus (HCV) and Inherited Bleeding Disorders

This study will determine the HCV antiviral efficacy, safety, and tolerability of treatment with Ledipasvir/Sofosbuvir (LDV/SOF) fixed-dose combination (FDC) for participants with genotype...

Ketamine Prevent POCD

Previous study demonstrated that neuroinflammation induced by surgery is the main cause of the postoperative cognitive dysfunction. As an agonist of NMDA receptor, ketamine is proved to be...

A Multiple Dose Study of MK-5172 in Hepatitis C-Infected Participants (MK-5172-010)

This study will compare hepatic pharmacokinetics (PK) derived from liver tissue to plasma PK after administration of MK-5172 to participants with chronic hepatitis C virus (HCV) infection....

Boceprevir in Subjects With Chronic Hepatitis C Genotype 1 Who Failed Prior Treatment With Peginterferon/Ribavirin (Study P05101AM3)(COMPLETED)

This study involves treatment with boceprevir or placebo in combination with pegylated interferon alfa-2b (PegIntron, PEG2b) + Ribavirin (RBV) (weight-based dosing [WBD]) in adult subjects...

POTENTE Study: A Study of Early Virological Response in Naive Patients With Chronic Hepatitis C, Genotype 2 or 3, Treated With PEGASYS (Peginterferon Alfa-2a (40KD)) Plus Copegus (Ribavirin).

This single arm study will investigate the predictive value of a week 4 virologi cal response on sustained virological response in patients with chronic hepatiti s C, genotype 2 or 3, trea...

An Observational Study of Pegasys (Peginterferon Alfa-2a) in Patients With HBeAg-Positive Chronic Hepatitis B in Vietnam

This prospective, multicenter, observational study will evaluate the sustained r esponse in patients with HBeAg positive chronic hepatitis B who are treated with Pegasys according to stand...

USG Nerve Blocks for ACL Reconstruction

Anterior cruciate ligament reconstruction is a routine surgical procedure. Traditional femoral/sciatic block combinations effectively reduce postoperative pain, but results in considerable...

Medical and Biotech [MESH] Definitions

INFLAMMATION of the LIVER in humans due to infection by VIRUSES. There are several significant types of human viral hepatitis with infection caused by enteric-transmission (HEPATITIS A; HEPATITIS E) or blood transfusion (HEPATITIS B; HEPATITIS C; and HEPATITIS D).

A family of hepatotropic DNA viruses which contains double-stranded DNA genomes and causes hepatitis in humans and animals. There are two genera: AVIHEPADNAVIRUS and ORTHOHEPADNAVIRUS. Hepadnaviruses include HEPATITIS B VIRUS, duck hepatitis B virus (HEPATITIS B VIRUS, DUCK), heron hepatitis B virus, ground squirrel hepatitis virus, and woodchuck hepatitis B virus (HEPATITIS B VIRUS, WOODCHUCK).

A species in the genus HEPATOVIRUS containing one serotype and two strains: HUMAN HEPATITIS A VIRUS and Simian hepatitis A virus causing hepatitis in humans (HEPATITIS A) and primates, respectively.

INFLAMMATION of the LIVER in humans caused by HEPATITIS DELTA VIRUS, a defective RNA virus that can only infect HEPATITIS B patients. For its viral coating, hepatitis delta virus requires the HEPATITIS B SURFACE ANTIGENS produced by these patients. Hepatitis D can occur either concomitantly with (coinfection) or subsequent to (superinfection) hepatitis B infection. Similar to hepatitis B, it is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact.

INFLAMMATION of the LIVER in humans caused by HEPATITIS C VIRUS, a single-stranded RNA virus. Its incubation period is 30-90 days. Hepatitis C is transmitted primarily by contaminated blood parenterally, and is often associated with transfusion and intravenous drug abuse. However, in a significant number of cases, the source of hepatitis C infection is unknown.

Search BioPortfolio:
Loading
Advertisement
Advertisement
review and buy Postoperative hepatitis market research data and corporate reports here

Channels Quicklinks